MX338951B - Formulaciones con contenido de extractos de echinacea angustifolia y zingiber officinale que son utiles para reducir la inflamacion y el dolor periferico. - Google Patents

Formulaciones con contenido de extractos de echinacea angustifolia y zingiber officinale que son utiles para reducir la inflamacion y el dolor periferico.

Info

Publication number
MX338951B
MX338951B MX2013000999A MX2013000999A MX338951B MX 338951 B MX338951 B MX 338951B MX 2013000999 A MX2013000999 A MX 2013000999A MX 2013000999 A MX2013000999 A MX 2013000999A MX 338951 B MX338951 B MX 338951B
Authority
MX
Mexico
Prior art keywords
useful
zingiber officinale
echinacea angustifolia
formulations containing
reducing inflammation
Prior art date
Application number
MX2013000999A
Other languages
English (en)
Other versions
MX2013000999A (es
Inventor
Paolo Morazzoni
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43739919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX338951(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena Spa filed Critical Indena Spa
Publication of MX2013000999A publication Critical patent/MX2013000999A/es
Publication of MX338951B publication Critical patent/MX338951B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a el uso de una combinación de extractos lipofílicos de Zingiber officinale y Echinacea angustifolia en la fabricación de un medicamento para el tratamiento del prurito; dolor periférico; trastornos inflamatorios y dolorosos superficiales o profundos; dolor asociado a espasmos musculares; dolor causado por herpes; radiodermatitis inducida por radioterapia oncológica con o sin infecciones fúngicas o bacterianas; edema y trastornos de irritación cutánea, incluyendo los debidos a excesiva exposición a la luz solar. Se describe una combinación de extractos lipofílicos de Zingiber officinale y Echinacea angustifolia para el tratamiento del prurito, dolor periférico, trastornos inflamatorios y dolorosos superficiales o profundos, dolor asociado a espasmos musculares, dolor causado por herpes, y radiodermatitis inducida por radioterapia oncológica, con o sin infecciones fúngicas o bacterianas.
MX2013000999A 2010-07-26 2011-07-20 Formulaciones con contenido de extractos de echinacea angustifolia y zingiber officinale que son utiles para reducir la inflamacion y el dolor periferico. MX338951B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A001373A IT1401141B1 (it) 2010-07-26 2010-07-26 Formulazioni contenenti estratti di echinacea angustifolia e di zingiber officinale utili nella riduzione dell'infiammazione e del dolore periferico
PCT/EP2011/062421 WO2012013551A1 (en) 2010-07-26 2011-07-20 Formulations containing extracts of echinacea angustifolia and zingiber officinale which are useful in reducing inflammation and peripheral pain

Publications (2)

Publication Number Publication Date
MX2013000999A MX2013000999A (es) 2013-03-22
MX338951B true MX338951B (es) 2016-05-05

Family

ID=43739919

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013000999A MX338951B (es) 2010-07-26 2011-07-20 Formulaciones con contenido de extractos de echinacea angustifolia y zingiber officinale que son utiles para reducir la inflamacion y el dolor periferico.

Country Status (22)

Country Link
US (2) US9283259B2 (es)
EP (1) EP2598156B1 (es)
JP (1) JP5996534B2 (es)
KR (1) KR101812746B1 (es)
CN (1) CN103096907B (es)
AR (1) AR082342A1 (es)
AU (1) AU2011285025B2 (es)
BR (1) BR112013001838A2 (es)
CA (1) CA2806428C (es)
CL (1) CL2013000241A1 (es)
DK (1) DK2598156T3 (es)
ES (1) ES2477548T3 (es)
HR (1) HRP20140583T8 (es)
IL (1) IL224388A (es)
IT (1) IT1401141B1 (es)
MX (1) MX338951B (es)
PL (1) PL2598156T3 (es)
PT (1) PT2598156E (es)
RU (1) RU2565436C2 (es)
SG (1) SG187601A1 (es)
SI (1) SI2598156T1 (es)
WO (1) WO2012013551A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121317A1 (it) 2012-07-27 2014-01-28 Indena Spa Composizioni per il trattamento della fatica oncologica
KR102440040B1 (ko) * 2013-03-14 2022-09-02 마리 케이 인코포레이티드 화장품 조성물들
ITMI20130807A1 (it) * 2013-05-16 2014-11-17 Indena Spa Combinazioni di estratti di serenoa repens e di estratti lipofili di zingiber officinalis e di echinacea angustifolia, loro uso e formulazioni che li contengono
US10086033B2 (en) * 2013-12-24 2018-10-02 Innovative Herbal Products (Aust) Pty Ltd Treatment of pain
BR112016018973B1 (pt) * 2014-02-20 2021-01-19 Indena S.P.A. composição e uso de uma composição
CN103961482A (zh) * 2014-04-23 2014-08-06 湖州康企药业有限公司 一种治疗皮炎的天然药物
DE202015006894U1 (de) 2015-08-31 2015-12-21 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Zusammensetzungen enthaltend einen Extrakt aus Echinacea und Linolsäurederivate
EP3150214A1 (en) * 2015-10-01 2017-04-05 INDENA S.p.A. Compositions containing extracts of curcuma spp and zingiber officinale which are useful to reduce peripheral inflammation and pain
ITUB20161030A1 (it) * 2016-02-24 2017-08-24 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
KR101684218B1 (ko) * 2016-04-04 2016-12-07 이경복 통증 완화를 위한 에센셜 오일
BR112018074709B1 (pt) * 2016-05-30 2022-01-18 Symrise Ag Medicamento compreendendo esclareolido, método não terapêutico para tratamento da hiperpigmentação induzida por luz visível na faixa de 400 nm a 700 nm, e uso cosmético não terapêutico de esclareolido
ITUA20164757A1 (it) * 2016-06-29 2017-12-29 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore osteoarticolare e del danno cartilagineo
EP3335716A1 (en) * 2016-12-15 2018-06-20 Indena S.p.A. Process for the preparation of powder compositions
EP3607959A1 (en) * 2018-08-10 2020-02-12 Raman Mehta Formulations containing lipophilic extracts of spicy edible plants useful in controlling pain and inflammation
US11147835B1 (en) 2020-08-20 2021-10-19 Frank Kelly Reilly, III Nutritional supplement

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2075187T3 (es) * 1990-07-05 1995-10-01 Indena Spa Extractos de equinaceas, un procedimiento para su preparacion y formulaciones que los contienen.
JP3030062B2 (ja) * 1990-07-26 2000-04-10 インデナ・ソチエタ・ペル・アチオニ エキナセア抽出物、抽出物の製造方法及びそれらを含む製剤
WO1999021007A1 (en) * 1997-10-23 1999-04-29 Pharmaprint, Inc. Pharmaceutical grade echinacea
US20010046523A1 (en) * 2000-02-25 2001-11-29 Thomas Newmark Ginger-based herbal composition for promoting health and methods of using same
US6274177B1 (en) * 2000-08-26 2001-08-14 National Science Council Method of preparing an extract potent in anti-inflammation and anti-platelet aggregation from Zingiber officinale and pharmaceutical compositions containing said extract
CN1279963C (zh) * 2001-06-07 2006-10-18 财团法人制药工业技术发展中心 从姜制备含抗发炎、抗血小板凝集或抗菌活性的有效成分的产品及方法和产品的医药组成物
US20030157185A1 (en) * 2002-02-08 2003-08-21 Lou Paradise Topical treatment of neuropathy
ITMI20021691A1 (it) * 2002-07-30 2004-01-30 Indena Spa Estratti di echinacea angustifolia
ITMI20032286A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne
JP5303697B2 (ja) * 2005-10-26 2013-10-02 オリザ油化株式会社 抗炎症剤
US7282224B1 (en) * 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
US20080160116A1 (en) * 2006-12-07 2008-07-03 Herbalscience Singapore Pte. Ltd Compositions and Methods Comprising Zingiber Species
CN101125136B (zh) * 2006-12-26 2010-06-02 广东药学院 高良姜二苯基庚烷类化合物在镇痛抗炎中的应用及其提取方法
EP2009023A1 (en) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Novel peptides and their use for the treatment of edema
US7824986B2 (en) * 2008-11-05 2010-11-02 Micron Technology, Inc. Methods of forming a plurality of transistor gates, and methods of forming a plurality of transistor gates having at least two different work functions
ITMI20090049A1 (it) * 2009-01-20 2010-07-21 Indena Spa Composizioni a base di estratti lipofili di zingiber officinale e di echinacea angustifolia per la prevenzione e il trattamento del riflusso gastro-esofageo e dell'emesi indotta da chemioterapici

Also Published As

Publication number Publication date
JP5996534B2 (ja) 2016-09-21
US9283259B2 (en) 2016-03-15
PL2598156T3 (pl) 2014-10-31
AU2011285025A1 (en) 2013-02-07
JP2013532671A (ja) 2013-08-19
AR082342A1 (es) 2012-11-28
AU2011285025B2 (en) 2014-03-20
HRP20140583T8 (hr) 2014-10-24
US9839663B2 (en) 2017-12-12
SG187601A1 (en) 2013-03-28
CN103096907B (zh) 2016-06-08
KR20130041137A (ko) 2013-04-24
ITMI20101373A1 (it) 2012-01-27
ES2477548T3 (es) 2014-07-17
CL2013000241A1 (es) 2013-05-03
US20160151441A1 (en) 2016-06-02
EP2598156B1 (en) 2014-05-14
EP2598156A1 (en) 2013-06-05
CN103096907A (zh) 2013-05-08
DK2598156T3 (da) 2014-06-30
PT2598156E (pt) 2014-07-16
BR112013001838A2 (pt) 2016-05-31
RU2013103334A (ru) 2014-07-27
WO2012013551A1 (en) 2012-02-02
CA2806428A1 (en) 2012-02-02
RU2565436C2 (ru) 2015-10-20
HRP20140583T1 (hr) 2014-08-01
US20130266672A1 (en) 2013-10-10
MX2013000999A (es) 2013-03-22
IL224388A (en) 2016-05-31
SI2598156T1 (sl) 2014-08-29
KR101812746B1 (ko) 2017-12-27
IT1401141B1 (it) 2013-07-12
CA2806428C (en) 2020-08-25

Similar Documents

Publication Publication Date Title
MX338951B (es) Formulaciones con contenido de extractos de echinacea angustifolia y zingiber officinale que son utiles para reducir la inflamacion y el dolor periferico.
MX2012007933A (es) Composiciones de dexmedetomidina transdermicas topicas y metodos para su uso.
WO2011139348A3 (en) Uses of phospholipid conjugates of synthetic tlr7 agonists
MY160041A (en) Compositions and methods for treating parasitic infections
MX365427B (es) Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas.
WO2012045090A3 (en) Therapeutic use of a tlr agonist and combination therapy
MX2015001122A (es) Combinaciones farmaceuticas de un inhibidor de cdk4/6 y un inhibidor de b-raf.
MY165086A (en) Formulations of rifaximin and uses thereof
EP2513343A4 (en) METHODS AND COMPOSITIONS FOR TREATING SKIN INFLAMMATION
EP2073819A4 (en) TOPICAL FORMULATIONS CONTAINING CO-ENZYME Q10 AND TREATMENT OF PAIN, FATIGUE AND WOUNDS
MX2014000066A (es) Formulaciones mucoadhesivas en gel de alta dosificación de metronidazol de base acuosa y su uso para tratar la vaginosis bacteriana.
MX2012014521A (es) Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado comun e inflamacion.
MX367091B (es) Una composición farmacéutica o cosmética tópica que comprende un extracto de la baya de la fruta milagrosa (synsepalum dulcificum) para usarse en el tratamiento o la prevención de desórdenes en la piel, mebrana mucosa, cabello, articulaciones y uñas.
PL2575971T3 (pl) Połączone wyciągi roślinne do zastosowania w leczeniu zakażeń drobnoustrojami
MX2019008817A (es) Formulacion de liberacion prolongada para reducir la frecuencia de miccion y metodo de uso de la misma.
WO2014153385A3 (en) Methods of treating metabolic disorders
MX2013008175A (es) Composiciones farmacéuticas para suministro tópico de fotosensibilizadores y usos de los mismos.
SA113340494B1 (ar) تركيبة لعلاج اضطرابات أيضية
CO6541630A2 (es) Combinación teobromina con un descongestivo y su uso para el tratamiento de la tos
WO2015063613A3 (en) Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
MX345124B (es) Bacteria novedosa y estractos de la bacteria y el uso de la misma en terapia.
WO2011056604A3 (en) Treatment of sunburn using analgesics and antihistamines
WO2012006585A3 (en) Use of interleukin-15 to treat cardiovascular diseases
HUE047515T2 (hu) N-Szubsztituált benzolpropánamidok fájdalom és gyulladás kezelésében történõ alkalmazásra
NZ598124A (en) Compounds for treatment of inflammation

Legal Events

Date Code Title Description
FG Grant or registration